Guidelines aim to support GPs in providing best treatments based on individuals with diabetes and their self-management of the condition.
A set of guidelines for GPs to support personalisation of care and prevent over-treatment for people with diabetes has been published by NICE.
The National Institute for Health and Care Excellence (NICE) has published the nine new indicators as part of NICE’s Quality and Outcomes Framework (QOF) following a consultation during the summer.
Eight of the new indicators focus on diabetes with the aim of helping GPs identify which people can most benefit from good control of their diabetes, and support the personalisation of care.
This could include stopping prescribing certain treatments that may have limited benefit depending on the person with diabetes and how good their self-management is.
The new guidelines support existing NICE recommendations on cardiovascular risk assessments and statin treatment for people with type 2 diabetes.
In addition, guidance on the use of statins by people with type 1 diabetes has been updated to simplify measurement.
The guidelines aim to improve patient outcomes and decrease the risk of harm from overtreatment, following the recommendation of a recent review of the QOF in England.
Professor Gillian Leng, Deputy Chief Executive and Director of Health and Social Care at NICE, said: “A number of the new NICE indicators for people with diabetes take account of frailty and are a step towards helping enable the greater personalisation of care. The intent of these indicators is to reduce the risk of treatment-related harm and improve the quality of life for people with moderate or severe frailty.”